Karoksazon

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
Karoksazon
(IUPAC) ime
2-(2-okso-4H-1,3-benzoksazin-3-il)acetamid
Klinički podaci
Identifikatori
CAS broj 18464-39-6
ATC kod nije dodeljen
PubChem[1][2] 29083
ChemSpider[3] 27057
UNII 807N226MNL YesY
Hemijski podaci
Formula C10H10N2O3 
Mol. masa 206,20 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status ℞ Prescription only
Način primene Oralno

Karoksazon (Surodil, Timostenil) je antidepresiv koji se nekad koristio za tretman depresije ali više nije u prodaji.[4][5] On deluje kao reverzibilni inhibitor monoaminske oksidaze (MAOI) oba podtipa: MAO-A i MAO-B, sa pet puta većom potentnošću na MAO-B.[6][7][8][9][10]

Reference[uredi - уреди | uredi kôd]

  1. ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737.  edit
  2. ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. http://www.jcheminf.com/content/2/1/3.  edit
  4. ↑ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8. http://books.google.com/books?id=zNZfxR-CsYcC&lpg=PA1254&dq=caroxazone&as_brr=3&pg=PA1254#v=onepage&q=&f=false. 
  5. ↑ Cecchini S, Petri P, Ardito R, Bareggi SR, Torriti A (1978). „A comparative double-blind trial of the new antidepressant caroxazone and amitriptyline”. The Journal of International Medical Research 6 (5): 388–94. PMID 359383. 
  6. ↑ Lieberman, A. N. (1994). Monoamine oxidase inhibitors in neurological diseases. New York: M. Dekker. ISBN 0-8247-9082-0. http://books.google.com/books?id=kJP3f9YKSrUC&lpg=PA56&ots=XKfRcAphTU&dq=caroxazone%20%22MAO-A%22&pg=PA56#v=onepage&q=&f=false. 
  7. ↑ Moretti A, Caccia C, Martini A, et al. (May 1981). „Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers”. British Journal of Clinical Pharmacology 11 (5): 511–5. PMC 1401585. PMID 7272163. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1401585/. 
  8. ↑ Moretti A, Caccia C, Calderini G, Menozzi M, Amico A (October 1981). „Studies on the mechanism of action of caroxazone, a new antidepressant drug”. Biochemical Pharmacology 30 (19): 2728–31. DOI:10.1016/0006-2952(81)90549-9. PMID 6170295. 
  9. ↑ Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A (June 1981). „Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man”. British Journal of Clinical Pharmacology 11 (6): 611–5. PMC 1402186. PMID 7272178. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1402186/. 
  10. ↑ Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A, Braibanti E (June 1981). „Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man”. British Journal of Clinical Pharmacology 11 (6): 605–10. PMC 1402193. PMID 7272177. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1402193/. 

Literatura[uredi - уреди | uredi kôd]

Vidi još[uredi - уреди | uredi kôd]

Spoljašnje veze[uredi - уреди | uredi kôd]

Portal Medicina
Portal Hemija
Izvor: https://sh.wikipedia.org/w/index.php?title=Karoksazon&oldid=4040685